Trisomy 21: 91% Detection rate using second-trimester ultrasound markers

Ultrasound in Obstetrics and Gynecology

Volumn 16, Issue 2, 2000, Pages 133-141

  DeVore, G R ^a,b  

^a Alfigen Inc   (United States)

^b Fetal Diagnostic Center   (United States)

Author keywords

Fetal echocardiography; Prenatal diagnosis; Trisomy 21; Ultrasound

Indexed keywords

AMNIOCENTESIS; ARTICLE; CENTRAL NERVOUS SYSTEM MALFORMATION; CHROMOSOME ABERRATION; COLOR ULTRASOUND FLOWMETRY; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FETUS; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REAL TIME ECHOGRAPHY; SECOND TRIMESTER PREGNANCY; TRISOMY; TRISOMY 21; ULTRASOUND;

ADULT; AMNIOCENTESIS; DOWN SYNDROME; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FETAL HEART; GENETIC MARKERS; HUMANS; LOGISTIC MODELS; MATERNAL AGE; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, THIRD; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 0034546870     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.2000.00203.x     Document Type: Article

References (52)

1. A sonographic screening method for Down syndrome
2. Sonographic identification of second-trimester fetuses with Down's syndrome
3. Sonographic measurements and ratios in fetuses with Down syndrome
4. Fetal biometry as a screening tool for the detection of chromosomally abnormal pregnancies
5. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels
6. The efficacy of fetal sonographic biometry in Down syndrome screening
7. Fetal femur length to detect trisomy 21. A reappraisal
8. Screening for trisomy 21 with ultrasonographic determination of biparietal diameter/femur length ratio
9. Femur length shortening in the detection of Down syndrome: Is prenatal screening feasible?
10. Biparietal diameter/femur length ratio, cephalic index, and femur length measurements: Not reliable screening techniques for Down syndrome
11. Is a short femur length a useful ultrasound marker for Down's syndrome?
12. Ultrasonographic screening for the Down syndrome fetus
13. Fetal body ratios in second trimester: A useful tool for identifying chromosomal abnormalities?
14. Soft tissue nuchal fold in the second-trimester fetus: Standards for normal measurements compared with those in Down syndrome
15. Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: Results of a prospective clinical trial
16. Fetal pyelectasis: A possible association with Down syndrome
17. Sonographic demonstration of hypoplasia of the middle phalanx of the fifth digit: A finding associated with Down syndrome
18. Hypoplasia of the middle phalanx of the fifth digit. A feature of the second trimester fetus with Down's syndrome
19. Prenatal sonographic findings of Down syndrome: Review of 94 cases
20. Sonographic diagnosis of Down syndrome in the second trimester
21. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome
22. Down syndrome: Sonographic sign for diagnosis in the second-trimester fetus
23. Fetal echocardiography. VII. Doppler color flow mapping: A new technique for the diagnosis of congenital heart disease
24. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: An alternative for high-risk patients who decline genetic amniocentesis
25. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography
26. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram?
27. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers
28. Genetic services in the United States
29. The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy
30. Color Doppler identification of a pericardial effusion in the fetus
31. Color Doppler examination of the outflow tracts of the fetal heart: A technique for identification of cardiovascular malformations
32. Fetal echocardiography: Factors that influence imaging of the fetal heart during the second trimester of pregnancy
33. Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative European study on 52 965 amniocenteses
34. Decision analysis
35. Choroid plexus cysts: Not associated with Down syndrome
36. First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21
37. Study of Down syndrome in 238 942 consecutive births
38. Congenital heart disease in infants with Down's syndrome
39. Improved ascertainment of cardiovascular malformations in infants with Down's syndrome, Atlanta, 1968 through 1989. Implications for the interpretation of increasing rates of cardiovascular malformations in surveillance systems
40. The association between congenital heard disease (CHD) and Down syndrome (DS) in the fetus
41. Characterization and natural history of ventricular septal defects in the fetus
42. Subtle ultrasonographic anomalies: Do they improve the Down syndrome detection rate?
43. An alternative for women initially declining genetic amniocentesis: Individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers
44. Second-trimester ultrasound markers for detection of trisomy 21: Which markers are best?
45. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: Description of the method and analysis of 142 cases
46. Best second trimester sonographic markers for the detection of trisomy 21
47. An economic evaluation of second-trimester genetic ultrasonography for prenatal detection of Down syndrome
48. Prevalence of aneuploidy with a cardiac intraventricular echogenic focus in an at-risk patient population
49. Significance of an echogenic intracardiac focus in fetuses at high and low risk for aneuploidy
50. Significance of fetal intracardiac echogenic foci in relation to trisomy 21: A prospective sonographic study of high-risk pregnant women
51. The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down's syndrome